Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06578429 · ClinicalTrials.gov registry record · NA

Deep TMS of Neural Circuits Associated With Stimulant Use Disorder

A NA study of Methamphetamine Use Disorder and Transcranial Magnetic Stimulation, sponsored by Stanford University.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06578429: Recruiting NA study of Methamphetamine Use Disorder and Transcranial Magnetic Stimulation, sponsored by Stanford University.

NCT06578429 is a NA study of Methamphetamine Use Disorder and Transcranial Magnetic Stimulation that is actively recruiting participants, run by Stanford University. The registered enrollment target is 30 participants, below the 53-participant average among 12 other Methamphetamine Use Disorder trials with a reported enrollment target (43% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06578429, a NA study of Methamphetamine Use Disorder and Transcranial Magnetic Stimulation, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This study aims to evaluate the efficacy of deep transcranial magnetic stimulation (dTMS) as a treatment for Veterans with a methamphetamine use disorder (MUD).

Primary Outcome

The primary measure of SN function will include insula activation during the monetary incentive delay task, anticipation of loss contrasted with no loss

Conditions Studied

Methamphetamine Use Disorder Transcranial Magnetic Stimulation

Interventions

  • DEVICE Deep Transcranial Magnetic Stimulation (dTMS) H4 coil - Active
  • DEVICE Deep Transcranial Magnetic Stimulation (dTMS) H4 coil - Sham

Study Locations (1)

California

  • VA Palo Alto Health Care System - Palo Alto

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-03-15
Est. Completion 2026-12-31
Phase NA
Stanford University

1,744 total trials

What NCT06578429 shows while recruiting

NCT06578429 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 53-participant average among 12 other Methamphetamine Use Disorder trials with a reported enrollment target (43% lower).

The record links to 2 conditions, with Methamphetamine Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Deep Transcranial Magnetic Stimulation (dTMS) H4 coil - Active is the first listed.

NCT06578429 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06578429 about?

NCT06578429 is a clinical study titled "Deep TMS of Neural Circuits Associated With Stimulant Use Disorder". This study aims to evaluate the efficacy of deep transcranial magnetic stimulation (dTMS) as a treatment for Veterans with a methamphetamine use disorder (MUD).

What is the current status of trial NCT06578429?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-03-15. Estimated completion is 2026-12-31.

What conditions does trial NCT06578429 study?

This clinical trial studies the following conditions: Methamphetamine Use Disorder, Transcranial Magnetic Stimulation.

What interventions are being tested in trial NCT06578429?

The interventions under investigation include: Deep Transcranial Magnetic Stimulation (dTMS) H4 coil - Active (DEVICE), Deep Transcranial Magnetic Stimulation (dTMS) H4 coil - Sham (DEVICE).

Who is sponsoring clinical trial NCT06578429?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06578429 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Methamphetamine Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06578429's enrollment target sits among peer trials

30 6th of 12 higher than 7 of 12 other Methamphetamine Use Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Methamphetamine Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06578429

Source: ClinicalTrials.gov NCT06578429, the US trial registry maintained by the National Library of Medicine. NCT06578429 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.